February 01, 2015 5:11 PM ET


Company Overview of Cephalon Limited

Company Overview

Cephalon Limited, a pharmaceutical company, offers hospital medicines in critical care, oncology, and pain management. The company offers licensors late stage development, pre and post approval, and marketing services in Europe for specialty hospital medicines. The company was formerly known as Zeneus Pharma Limited and changed its name to Cephalon Limited in October, 2006. The company was founded in 2004 and is based in Oxford, United Kingdom with additional locations in the United Kingdom, France, Germany, Italy, Spain, Ireland, Austria, Benelux, Portugal, and Switzerland, as well as in Eastern Europe and Scandinavia.Cephalon Limited operates as a subsidiary of Cephalon Inc.

The Magdalen Centre

Oxford Science Park

Oxford,  OX4 4GA

United Kingdom

Founded in 2004


44 18 6578 4800


44 18 6578 4801

Key Executives for Cephalon Limited

Age: 47
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cerogenix Ltd. Europe
Glaxo Group Limited Europe
Enigma Therapeutics Ltd Europe
Cardinal Health U.K. 432 Limited Europe
Bristol-Myers Squibb Pharmaceuticals Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cephalon Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.